Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 10991997)

1.

Bupropion is a nicotinic antagonist.

Slemmer JE, Martin BR, Damaj MI.

J Pharmacol Exp Ther. 2000 Oct;295(1):321-7.

2.

Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity.

Damaj MI, Flood P, Ho KK, May EL, Martin BR.

J Pharmacol Exp Ther. 2005 Feb;312(2):780-5. Epub 2004 Sep 8.

3.

Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.

Damaj MI, Slemmer JE, Carroll FI, Martin BR.

J Pharmacol Exp Ther. 1999 Jun;289(3):1229-36.

4.

Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.

Sidhpura N, Redfern P, Wonnacott S.

Eur J Pharmacol. 2007 Jul 12;567(1-2):102-9. Epub 2007 Apr 6.

PMID:
17477919
5.

Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.

Sidhpura N, Redfern P, Rowley H, Heal D, Wonnacott S.

Biochem Pharmacol. 2007 Oct 15;74(8):1292-8. Epub 2007 Jun 21.

PMID:
17678630
8.

Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.

Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.

Brain Res. 2006 Oct 30;1117(1):18-24. Epub 2006 Sep 1.

PMID:
16949560
9.

Nicotine-like discriminative stimulus effects of bupropion in rats.

Wiley JL, Lavecchia KL, Martin BR, Damaj MI.

Exp Clin Psychopharmacol. 2002 May;10(2):129-35.

PMID:
12022798
11.
12.

Nicotine and bupropion share a similar discriminative stimulus effect.

Young R, Glennon RA.

Eur J Pharmacol. 2002 May 17;443(1-3):113-8.

PMID:
12044800
13.

In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice.

Damaj MI, Welch SP, Martin BR.

Psychopharmacology (Berl). 1995 Jan;117(1):67-73.

PMID:
7724704
14.

Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.

Bevins RA, Wilkinson JL, Palmatier MI, Siebert HL, Wiltgen SM.

Psychopharmacology (Berl). 2006 Mar;184(3-4):470-81. Epub 2005 Jul 27.

PMID:
16047193
15.

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.

Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR.

Mol Pharmacol. 2004 Sep;66(3):675-82.

17.
18.
19.

U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.

Zheng C, Wang MY, Liu Q, Wakui M, Whiteaker P, Lukas RJ, Wu J.

J Neurochem. 2009 Mar;108(6):1526-38. doi: 10.1111/j.1471-4159.2009.05903.x. Epub 2009 Feb 16.

PMID:
19183258
20.

Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes.

Papke RL, Sanberg PR, Shytle RD.

J Pharmacol Exp Ther. 2001 May;297(2):646-56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk